Cost of active ACC claims for adverse reactions to medications in New Zealand
Year ended June 2011–2018, NZD millions
| Year ended June | NZD |
|---|---|
| 2011 | 6,237,684 |
| 2012 | 6,448,323 |
| 2013 | 6,400,904 |
| 2014 | 8,164,929 |
| 2015 | 8,753,586 |
| 2016 | 10,059,895 |
| 2017 | 12,178,762 |
| 2018 | 13,185,542 |